The Effects of AMPC in the Treatments of Refractory or Relapsed AML

Clinical trial NCT03825146 · UNKNOWN

Trial details

NCT number: NCT03825146
Sponsor: Lai Corporation Pty. Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukaemia Recurrent

Start date: 2019-01-04
Primary completion: 2021-01-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.